DENVER, CO--(NewMediaWire - May 11, 2016) - American
Cannabis Company, Inc. (OTCQB: AMMJ) (the "Company"), a full-service
business-to-business consulting solutions provider, and seller of
ancillary products to the cannabis industry, today announced it has
signed a new client in Pennsylvania for the state's upcoming
medical marijuana application.
Corey Hollister, president and CEO of American Cannabis Company,
commented: "We are very excited to be working with this tremendous
team. The merit-based application process has become the preferred
method for the majority of states adopting medical marijuana
programs, and the competition and complexity has increased steadily
with each state. Our client understands that to be successful they
need to be proactive and attack the process starting now.
About American Cannabis Company, Inc.:
American Cannabis Company, Inc. offers end-to-end solutions to
existing and aspiring participants in the cannabis industry. We
utilize our industry expertise to provide business planning and
market assessment services, assist state licensing procurement,
create business infrastructure and operational best practices.
Through our two vertically integrated businesses, American Cannabis
Consulting and American Cultivator Company, a group purchasing
organization, we support our clients from concept to creation to
commercialization to on-going operations.
For more information, please visit: www.americancannabiscompanyinc.com.
Forward Looking Statements
This news release contains "forward-looking statements" which
are not purely historical and may include any statements regarding
beliefs, plans, expectations or intentions regarding the future.
Such forward-looking statements include, among other things, the
development, costs and results of new business opportunities and
words such as "anticipate", "seek", intend", "believe", "estimate",
"expect", "project", "plan", or similar phrases may be deemed
"forward-looking statements" within the meaning of the Private
Securities Litigation Reform Act of 1995. Actual results could
differ from those projected in any forward-looking statements due
to numerous factors. Such factors include, among others, the
inherent uncertainties associated with new projects, the future
U.S. and global economies, the impact of competition, and the
Company's reliance on existing regulations regarding the use and
development of cannabis-based drugs. These forward-looking
statements are made as of the date of this news release, and we
assume no obligation to update the forward-looking statements, or
to update the reasons why actual results could differ from those
projected in the forward-looking statements. Although we believe
that any beliefs, plans, expectations and intentions contained in
this press release are reasonable, there can be no assurance that
any such beliefs, plans, expectations or intentions will prove to
be accurate. Investors should consult all of the information set
forth herein and should also refer to the risk factors disclosure
outlined in our annual report on Form 10-K for the most recent
fiscal year, our quarterly reports on Form 10-Q and other periodic
reports filed from time-to-time with the Securities and Exchange
Commission. For more information, please visit www.sec.gov.